135 related articles for article (PubMed ID: 24059241)
41. Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.
Padhiar AA; Chanda W; Joseph TP; Guo X; Liu M; Sha L; Batool S; Gao Y; Zhang W; Huang M; Zhong M
Appl Microbiol Biotechnol; 2018 Mar; 102(5):2363-2377. PubMed ID: 29387954
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
43. Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils.
Noormägi A; Primar K; Tõugu V; Palumaa P
J Pept Sci; 2012 Jan; 18(1):59-64. PubMed ID: 22083646
[TBL] [Abstract][Full Text] [Related]
44. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Kung MP; Hou C; Zhuang ZP; Zhang B; Skovronsky D; Trojanowski JQ; Lee VM; Kung HF
Brain Res; 2002 Nov; 956(2):202-10. PubMed ID: 12445687
[TBL] [Abstract][Full Text] [Related]
45. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates.
de Groot NS; Ventura S
J Biotechnol; 2006 Aug; 125(1):110-3. PubMed ID: 16621081
[TBL] [Abstract][Full Text] [Related]
46. Diphenylalanine as a Reductionist Model for the Mechanistic Characterization of β-Amyloid Modulators.
Brahmachari S; Arnon ZA; Frydman-Marom A; Gazit E; Adler-Abramovich L
ACS Nano; 2017 Jun; 11(6):5960-5969. PubMed ID: 28575577
[TBL] [Abstract][Full Text] [Related]
47. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
[TBL] [Abstract][Full Text] [Related]
48. In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates.
Brinet D; Gaie-Levrel F; Delatour V; Kaffy J; Ongeri S; Taverna M
Talanta; 2017 Apr; 165():84-91. PubMed ID: 28153323
[TBL] [Abstract][Full Text] [Related]
49. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
Asti A; Gioglio L
J Alzheimers Dis; 2014; 39(1):169-79. PubMed ID: 24150108
[TBL] [Abstract][Full Text] [Related]
50. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide.
Smith DP; Ciccotosto GD; Tew DJ; Fodero-Tavoletti MT; Johanssen T; Masters CL; Barnham KJ; Cappai R
Biochemistry; 2007 Mar; 46(10):2881-91. PubMed ID: 17297919
[TBL] [Abstract][Full Text] [Related]
51. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
52. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
53. Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy.
Ami D; Natalello A; Gatti-Lafranconi P; Lotti M; Doglia SM
FEBS Lett; 2005 Jun; 579(16):3433-6. PubMed ID: 15949804
[TBL] [Abstract][Full Text] [Related]
54. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
Loureiro JA; Rocha S; Pereira Mdo C
J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of amyloid-β aggregation in Alzheimer's disease.
Wang Q; Yu X; Li L; Zheng J
Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
[TBL] [Abstract][Full Text] [Related]
56. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
57. Assessing Aβ aggregation state by atomic force microscopy.
Legleiter J
Methods Mol Biol; 2011; 670():57-70. PubMed ID: 20967583
[TBL] [Abstract][Full Text] [Related]
58. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
[TBL] [Abstract][Full Text] [Related]
59. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation.
Webster S; Rogers J
J Neurosci Res; 1996 Oct; 46(1):58-66. PubMed ID: 8892106
[TBL] [Abstract][Full Text] [Related]
60. Application of an E. coli signal sequence as a versatile inclusion body tag.
Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J
Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
